Joshua Silverman Pharma Cyte Biotech, Inc. (PMCB) insider trading activity

Joshua Silverman is CEO and President of PharmaCyte Biotech, Inc.. Currently has a direct ownership of 316,250 shares of PMCB, which is worth approximately $249,837. The most recent transaction as insider was on Dec 12, 2025, when has been sold 258,750 shares (Common Stock) at a price of $1.02 per share, resulting in proceeds of $263,925. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 316K

n/a 3M change

n/a 12M change

Total Value Held $249,837

Joshua Silverman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 12 2025	SELL Payment of exercise price or tax liability	$263,925 $1.02 p/Share	258,750 Reduced 45.0%	316,250 Common Stock
Dec 12 2025	BUY Grant, award, or other acquisition	-	575,000 Added 50.0%	575,000 Common Stock

Also insider at

AYRO

AYRO, Inc. Consumer Cyclical

Chief Executive Officer

PTPI

Petros Pharmaceuticals, Inc. Healthcare

Director

MYMD

MyMD Pharmaceuticals, Inc. Healthcare

Executive Chairman

SNPX

Synaptogenix, Inc. Healthcare

Executive Chairman

FEMY

FEMASYS INC Healthcare